Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 9, 2009, Pages 3675-3682

  Ramón García, Santiago ^a,b,c   Martín, Carlos ^a,b   Thompson, Charles J ^c   Aínsa, José A ^a,b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CLOFAZIMINE; PROTEIN P55; RIFAMPICIN; VALINOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL GROWTH; CONTROLLED STUDY; ENZYME INACTIVATION; GENE DELETION; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN TRANSPORT;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CLOFAZIMINE; DITHIOTHREITOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GLUTATHIONE; HYDROGEN PEROXIDE; MEMBRANE TRANSPORT PROTEINS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RIFAMPIN; VALINOMYCIN;

EID: 70349154626     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00550-09     Document Type: Article

References (41)

1. Ahmed, M., C. M. Borsch, S. S. Taylor, N. Vazquez-Laslop, and A. A. Neyfakh. 1994. A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates. J. Biol. Chem. 269:28506-28513.
2. Ainsa, J. A., C. Martin, M. Cabeza, F. De la Cruz, and M. V. Mendiola. 1996. Construction of a family of Mycobacterium/Escherichia coli shuttle vectors derived from pAL5000 and pACYC184: their use for cloning an antibiotic-resistance gene from Mycobacterium fortuitum. Gene 176:23-26.
3. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520-1523. (Pubitemid 129524431)
4. Berridge, M. V., P. M. Herst, and A. S. Tan. 2005. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol. Annu. Rev. 11:127-152.
5. Bigi, F., A. Alito, M. I. Romano, M. Zumarraga, K. Caimi, and A. Cataldi. 2000. The gene encoding P27 lipoprotein and a putative antibiotic-resistance gene form an operon in Mycobacterium tuberculosis and Mycobacterium bovis. Microbiology 146(Pt 4):1011-1018. (Pubitemid 30201048)
6. Bigi, F., A. Gioffre, L. Klepp, M. de la Paz Santangelo, A. Alito, K. Caimi, V. Meikle, M. Zumarraga, O. Taboga, M. I. Romano, and A. Cataldi. 2004. The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis. Microbes Infect. 6:182-187.
7. Boshoff, H. I., T. G. Myers, B. R. Copp, M. R. McNeil, M. A. Wilson, and C. E. Barry III. 2004. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279:40174-40184.
8. Buroni, S., G. Manina, P. Guglierame, M. R. Pasca, G. Riccardi, and E. De Rossi. 2006. LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 50:4044-4052.
9. Colangeli, R., D. Helb, S. Sridharan, J. Sun, M. Varma-Basil, M. H. Hazbon, R. Harbacheuski, N. J. Megjugorac, W. R. Jacobs, Jr., A. Holzenburg, J. C. Sacchettini, and D. Alland. 2005. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol. Microbiol. 55:1829-1840.
10. Content, J., M. Braibant, N. D. Connell, and J. A. Ainsa. 2005. Transport processes, p. 379-401. In S. Cole, K. D. Eisenach, D. N. McMurray, and W. R. Jacobs, Jr. (ed.), Tuberculosis and the tubercle bacillus. ASM Press, Washington, DC.
11. De Rossi, E., J. A. Ainsa, and G. Riccardi. 2006. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol. Rev. 30:36-52.
12. De Rossi, E., P. Arrigo, M. Bellinzoni, P. A. Silva, C. Martin, J. A. Ainsa, P. Guglierame, and G. Riccardi. 2002. The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. Mol. Med. 8:714-724.
13. Farrow, M. F., and E. J. Rubin. 2008. Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein. J. Bacteriol. 190:1783-1791.
14. Grkovic, S., M. H. Brown, N. J. Roberts, I. T. Paulsen, and R. A. Skurray. 1998. QacR is a repressor protein that regulates expression of the Staphylococcus aureus multidrug efflux pump QacA. J. Biol. Chem. 273:18665-18673.
15. Gupta, A. K., D. S. Chauhan, K. Srivastava, R. Das, S. Batra, M. Mittal, P. Goswami, N. Singhal, V. D. Sharma, K. Venkatesan, S. E. Hasnain, and V. M. Katoch. 2006. Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. J. Commun. Dis. 38:246-254.
16. Janssen, G. R., and M. J. Bibb. 1993. Derivatives of pUC18 that have BglII sites flanking a modified multiple cloning site and that retain the ability to identify recombinant clones by visual screening of Escherichia coli colonies. Gene 124:133-134. (Pubitemid 23065980)
17. Jiang, X., W. Zhang, Y. Zhang, F. Gao, C. Lu, X. Zhang, and H. Wang. 2008. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb. Drug Resist. 14:7-11.
18. Kaatz, G. W., and S. M. Seo. 1995. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 39:2650-2655.
19. Krulwich, T. A., O. Lewinson, E. Padan, and E. Bibi. 2005. Do physiological roles foster persistence of drug/multidrug-efflux transporters? A case study. Nat. Rev. Microbiol. 3:566-572.
20. Lewinson, O., E. Padan, and E. Bibi. 2004. Alkali tolerance: a biological function for a multidrug transporter in pH homeostasis. Proc. Natl. Acad. Sci. USA 101:14073-14078.
21. Li, X. Z., and H. Nikaido. 2004. Efflux-mediated drug resistance in bacteria. Drugs 64:159-204.
22. Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
23. Newton, G. L., Y. Av-Gay, and R. C. Fahey. 2000. A novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidase. Biochemistry 39:10739-10746.
24. Nguyen, L., and C. J. Thompson. 2006. Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm. Trends Microbiol. 14:304-312. (Pubitemid 43963364)
25. Nishino, K., and A. Yamaguchi. 2001. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol. 183:5803-5812. (Pubitemid 32917397)
26. Parish, T., and N. G. Stoker. 1998. Mycobacterial protocols. In T. Parish and N. G. Stoker (ed.), Methods in molecular biology, vol.101. Humana Press, Totowa, NJ.
27. Parish, T., and N. G. Stoker. 2000. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146(Pt 8):1969-1975.
28. Pasca, M. R., P. Guglierame, E. De Rossi, F. Zara, and G. Riccardi. 2005. mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 49:4775-4777.
29. Piddock, L. J. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19:382-402.
30. Piddock, L. J. 2006. Multidrug-resistance efflux pumps-not just for resistance. Nat. Rev. Microbiol. 4:629-636.
31. Prentki, P., and H. M. Krisch. 1984. In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29:303-313.
32. Ramon-Garcia, S., C. Martin, J. A. Ainsa, and E. De Rossi. 2005. Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum. J. Antimicrob. Chemother. 57:252-259.
33. Ramon-Garcia, S., C. Martin, E. De Rossi, and J. A. Ainsa. 2007. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. J. Antimicrob. Chemother. 59:544-547. (Pubitemid 47073463)
34. Rawat, M., and Y. Av-Gay. 2007. Mycothiol-dependent proteins in actinomycetes. FEMS Microbiol. Rev. 31:278-292.
35. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Samper, S., and C. Martin. 2007. Spread of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13:647-648.
37. Sassetti, C. M., and E. J. Rubin. 2003. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA 100:12989-12994.
38. Siddiqi, N., R. Das, N. Pathak, S. Banerjee, N. Ahmed, V. M. Katoch, and S. E. Hasnain. 2004. Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. Infection 32:109-111.
39. Silva, P. E., F. Bigi, M. de la Paz Santangelo, M. I. Romano, C. Martin, A. Cataldi, and J. A. Ainsa. 2001. Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 45:800-804.
40. Stover, C. K., P. Warrener, D. R. VanDevanter, D. R. Sherman, T. M. Arain, M. H. Langhorne, S. W. Anderson, J. A. Towell, Y. Yuan, D. N. McMurray, B. N. Kreiswirth, C. E. Barry, and W. R. Baker. 2000. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405:962-966. (Pubitemid 30435054)
41. World Health Organization. 2008. Global tuberculosis control: surveillance, planning, financing: WHO report WHO/HTM/TB/2008.393. World Health Organization, Geneva, Switzerland.